Prostate cancer (PCa) is with rising incidence in male population globally. It is a complex
anomaly orchestrated by a plethora of cellular processes. Transforming growth factor-beta …

The incidence of prostate cancer is increasing worldwide and marks a significant health
issue. Paired with this, current therapeutic options for advanced prostate cancer, notably …

Prostate cancer (PC) is the third-leading cause of cancer-related deaths worldwide.
Although the current treatment strategies are progressing rapidly, PC is still representing a …

Background Several natural products, extensively studied for their anticancer activities, have
been found to play an efficient role in preventing prostate cancer (PCa). Recently many …

In developed countries, prostate cancer (PC) is the neoplasia more frequently diagnosed in
men. The signaling pathway induced by the transforming growth factor β1 (TGFβ1) has an …

Prostate cancer (PC) is a multifactorial disease characterized by the abrogation of androgen
receptor signaling. Advancement in microbiology techniques has highlighted the significant …

Transforming growth factor-β1 (TGF-β1) acts as a tumor promoter in advanced prostate
cancer (PCa). We speculated that microRNAs (miRNAs) that are inhibited by TGF-β1 might …

MicroRNAs are the non-coding RNAs which regulate endogenous gene expression in
animal and plant cells. Alterations in the level of micro-ribonucleic acids (miRNAs) involving …

Prostate cancer (PCa) is the fifth cause of tumor-related deaths in man worldwide. Despite
the considerable improvement in the clinical management of PCa, several limitations …

A novel class of gene regulators, small noncoding RNAs or microRNAs (miRNAs) has an
important role in various malignancies, including prostate cancer (PCa). Contribution of …